SCHEMBL14418376

SCHEMBL14418376

Cc1ccccc1/N=N/c1ccc(/N=N/c2c(O)ccc3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)c(C)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 4/20 0.65
▸ ALDH1A1 P00352 3/20 0.65
▸ PRMT1 Q99873 2/20 0.52
▸ ENPP2 Q13822 3/20 0.52
▸ HIF1A Q16665 3/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ TDP1 Q9NUW8 2/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ THRB P10828 1/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ ALOX12 P18054 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ SUMO2 P61956 1/20 0.51
▸ SUMO1 P63165 1/20 0.51
▸ SENP7 Q9BQF6 1/20 0.51
▸ SENP2 Q9HC62 1/20 0.51
▸ KMT2A Q03164 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29860575 0.84 PHLPP2 (0.55) MAPK1ALDH1A1PRMT1ENPP2HIF1A
SCHEMBL1098585 0.83 APP (0.69) MAPK1ALDH1A1PRMT1ENPP2HIF1A
SCHEMBL110351 0.83 APP (0.69) MAPK1ALDH1A1PRMT1ENPP2HIF1A
SCHEMBL461768 0.83 APP (0.69) MAPK1ALDH1A1PRMT1ENPP2HIF1A
SCHEMBL7921324 0.82 APP (0.67) MAPK1ALDH1A1PRMT1ENPP2HIF1A
SCHEMBL10625306 0.82 APP (0.67) MAPK1ALDH1A1PRMT1ENPP2HIF1A
Orange G SCHEMBL17279088 0.81 APP (0.70) MAPK1ALDH1A1PRMT1ENPP2HIF1A
Orange G SCHEMBL3020774 0.81 APP (0.70) MAPK1ALDH1A1PRMT1ENPP2HIF1A
Orange G SCHEMBL3020776 0.81 APP (0.70) MAPK1ALDH1A1PRMT1ENPP2HIF1A
Orange G SCHEMBL31621938 0.81 APP (0.70) MAPK1ALDH1A1PRMT1ENPP2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7264932-B2 Nuclease inhibitor cocktail APPLERA CORPORATION (US) 2007-09-04 — — US disclosed
US-20070032418-A1 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same AMBION, INC (US) 2007-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032418-A1 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same RNASE1, RNASEH1, RNASEL MAPK1 3346/4885ALDH1A1 2603/4885PRMT1 2506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback